ТИРОНЕТ – все о щитовидной железе Для специалистов Журнал Тиронет 2007 год № 3

Клинические аспекты заболеваний щитовидной железы у лиц пожилого возраста

В.В. Фадеев
Thyroid International №3 – 2007

ЛИТЕРАТУРА

1. ^ Mariotti SF, Franceschi C, Cossarizza A, Pinchera A. The aging thyroid. Endocrine Reviews 1995; 16: 686–715.
2. ^ Rehman SU, Cope DW, Senseney AD, Brzezinski W. Thyroid disorders in elderly patients. South Med J 2005; 98: 543–549.
3. ^ Bemben DA, Hamm RM, Morgan L, et al. Thyroid disease in the elderly. J Fam Pract 1994; 38: 583–588.
4. ^ Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526–534.
5. ^ Szabolcs I, Podoba J, Feldkamp J, et al. Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long-term iodine prophylaxis and abundant iodine intake. Clin Endocrinol 1997; 47: 87–92.
6. ^ Carle A, Laurberg P, Bulow Pedersen I, et al. Epidemiology of subtypes of hypothyroidism in Denmark. Eur J Endocrinol 2006; 154: 21–28.
7. ^ Fadeyev V, Zakharova S, Artemova A, Vanushko V, Melnichenko G. The epidemiology of the thyroid disorders in the elderly: results of screening in nursing homes in Moscow. Turkish J Endocrinology and Metab 2004; 8 (Suppl. 1): 142 (Abstracts of the 30th annual meeting of the European Thyroid Association).
8. ^ American College of Physicians. Clinical guideline. Part 1. Screening for thyroid diseases. Ann Intern Med 1998; 129: 141–143.
9. ^ AACE clinical practice guidelines for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocrine Practice 1995; 1: 56–62.
10. ^ Ladenson PW, Singer PA, Ain KB, et al. American thyroid association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000; 160: 1573–1575.
11. ^ Hak AE, Pols HA, Visser TJ, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. J Ann Intern Med 2000; 132: 270–278.
12. ^ Imaizumi M, Akahoshi M, Ichimaru S, et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab 2004; 89: 3365–3370.
13. ^ Walsh JP, Bremner AP, Bulsara MK, et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 2005; 165: 2467 – 2472.
14. ^ Rodondi N, Newman AB, Vittinghoff E, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 2005; 165: 2460–2466.
15. ^ Kong WM, Sheikh MH, Lumb PJ, et al. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. // Am J Med 2002; 112: 348–354.
16. ^ Gussekloo J, van Exel E, de Craen AJ, et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004; 292: 2591–2599.
17. ^ Van den Beld AW, Visser TJ, Feelders RA, Grobbee DE, Lamberts S. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J Clin Endocrinol Metab 2005; 90: 6403–6409.
18. ^ Diez J, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab 2004; 89: 4890–4897.
19. ^ Gharib H, Tuttle RM, Baskin HJ., Fish LH, Singer PA, McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. Endocr Pract 2004; 10: 497–501.
20. ^ Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228–238.
21. ^ Weetman AP. Whose thyroid hormone replacement is it anyway? Clin. Endocrinol 2006; 64: 231–233.
22. ^ Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer D. Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. The American Journal of Medicine 2006; 119: 541–551.
23. ^ Fadeyev VV, Sytch J, Kalashnikov V, Rojtman A, Syrkin A, Melnichenko G. Levothyroxine replacement therapy in patients with subclinical hypothyroidism and coronary artery disease. Endocr Pract 2006; 12: 5 – 17.
24. ^ Col NF, Surks MI, Daniels GH. Subclinical thyroid disease: clinical applications. JAMA 2004; 291: 239–243.
25. ^ Simons RJ, Simon JM, Demers LM, Santen RJ. Thyroid dysfunction in elderly hospitalized patients. Effect of age and severity of illness. Arch Intern Med 1990; 150: 1249–1253.
26. ^ Roos A, Linn-Rasker SP, van Domburg RT, et al. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch Intern Med 2005; 165: 1714–1720.
27. ^ Brochmann H, Bjoro T, Gaarder PI, et al. Prevalence of thyroid dysfunction in elderly subjects. A randomized study in a Norwegian rural community. Acta Endocrinol 1988; 117: 7–12.
28. ^ Ligthart GJ, Corberland JX, Geertzen HG, Meinders AE, Knook DL, Hijmans W. Necessity of the assessment of health status in human immunogerontological studies: evaluation of the SENIEUR protocol. Mech Ageing Dev 1990; 55: 89–105.
29. ^ Laurberg P, Pedersen KM, Hreidarsson A, et al. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 1998; 83: 765–769.
30. ^ Fadeyev V, Lesnikova S, Melnichenko G. Prevalence of thyroid disorders in pregnant women with mild iodine deficiency. Gynecological Endocrinology 2003; 17: 413 – 418.
31. ^ Sawin CT, Bigos ST, Land S, Bacharach P. The aging thyroid. Relationship between elevated serum thyrotropin level and thyroid antibodies in elderly patients. Am J Med 1985; 79: 591–595.
32. ^ Maugeri D, Russo SM, Carnazzo G, et al. Altered laboratory thyroid parameters indicating hyperthyroidism in elderly subjects. Arch Gerontol Geriatr 1996; 22: 145–153.
33. ^ Kennedy JW, Caro JF. The ABCs of managing hyperthyroidism in the older patient. Geriatrics 1996; 51: 22–32.
34. ^ Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. New Engl J Med 1994; 331: 1249–1252.
35. ^ Laurberg P, Bulow Pedersen I, Knudsen N, et al. Environmental iodine intake affects the type of nonmalignant thyroid disease. Thyroid 2001; 11: 457–469.
36. ^ Aghini-Lombardi F, Antonangeli L, Martino E et al. The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 1999; 84: 561–566.
37. ^ Diez J. Hyperthyroidism in patients older than 55 years: An analysis of the etiology and management. Gerontolog 2003; 49: 316–323.
38. ^ Tajiri J, Hamasaki S, Shimada T, et al. Masked thyroid dysfunction among elderly patients with atrial fibrillation. Jpn Heart J 1986; 27: 183–190.
39. ^ Parle JV, Franklyn JA, Cross KW, et al. Prevelence and follow-up of abnormal thyrotrophin (TSH) concentration in the elderly in the UK. Clin Endocrinol 1991; 34: 77–83.
40. ^ Mudde AH, Reijnders FJL, Kruseman C. Peripheral Bone Density in Women with Untreated Multinodular Goiter. Clinical Endocrinology 1992; 37: 35–39.
41. ^ Kalmijn S, Mehta KM, Pols HA, et al. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol 2000; 53:733–737.
42. ^ Frost L., Vestergaard P., Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med 2004; 164: 1675–1678.
43. ^ Ladenson PW. Thyrotoxicosis and the heart: old and something new. J Clin Endocrinol Metab 1993; 77: 332–333.
44. ^ Schicha H, Dietlein M. Morbus Basedow und Autonomie — Radioiodtherapie. Nuklearmedizin 2002; 41: 63–70.
45. ^ Franklyn JA, Sheppard MC, Maisonneuve P. Thyroid Function and Mortality in Patients Treated for Hyperthyroidism. JAMA 2005; 294: 71–80.
46. ^ Pearce SH. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clin Endocrinol (Oxf ) 2004; 61: 589–594.
47. ^ Zairattiants OV, Fadeev VV, Belotserkovskaia MM, et al. Nosological structure of thyroid nodular lesions by autopsy data. Arkh Patol 2004; 66: 24–88.
48. ^ Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16: 1–33.
49. ^ AACE/AME Task Force. Guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 2006; 12: 63–102.
50. ^ Kaplan MM. Thyroid carcinoma. Endocrin Metab Clin North Am 1990; 19: 469–478.
51. ^ Belfiore A, La Rosa G, La Porta G, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age and multinodularity. Am J Med 1992; 93: 363–369.
52. ^ Pacini F., Schlumberger M., Dralle H., et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinology 2006; 154: 787–803.